Public Health

Humana sell-off overdone after strong earnings. Jim Cramer says buy the stock

In this photo illustration, Humana Inc. logo seen displayed on a tablet.

Getty Images

The post-earnings decline in Humana (HUM) shares Wednesday was overdone, providing investors an opportunity to add to their positions in the Medicare Advantage-focused health insurer.

The Club holding remains on solid ground after delivering a top- and bottom-line beat in the third quarter.

Related Articles